Translational Development Acquisition Corp.
TDAC | NASDAQ
$10.87
+$0.02 (+0.18%)
At close: Sep 21, 2026, 4:00 PM ET
$10.87
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Company Profile
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Key Executives
| Name | Position |
|---|---|
| Michael Hoffman | Chairman of the Board & Chief Executive Officer |
| Avi C. Das | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 27, 2026 | 8-K | Current Report |
| Aug 18, 2026 | NT 10-Q | Filing |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Aug 14, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 10, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 03, 2026 | 425 | Filing |
| Jul 31, 2026 | 10-K/A | [Amend] Annual Report |
| Jul 30, 2026 | 8-K | Current Report |
Translational Development Acquisition Corp.
| Country | United States |
| IPO Date | Feb 19, 2025 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | 2 |
| CEO | Michael Hoffman |
Contact Details
52 E. 83rd Street New York City,
New York 10028 United States
Stock Details
| Ticker Symbol | TDAC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001926599 |
| CUSIP Number | G9008W105 |
| ISIN Number | KYG9008W1050 |
| SIC Code | 7372 |
Add to Watchlist
Select watchlists to add or remove TDAC